Anti-double-stranded DNA (anti-dsDNA) autoantibodies are archetypal biomarkers found in systemic lupus erythematosus (SLE). Although they can exist in any isotype, very little is understood about the IgA isotype for which most of our knowledge is derived from observational studies. This review article summarises our knowledge of this autoantibody isotype to date. Attention will be spent on clinical associations as well as its potential links with lupus nephritis for which there is still some controversy. Further understanding of this serological parameter may facilitate diagnosis, prognosis and treatments of systemic lupus erythematosus patients.
WoofJMRussellMW. Structure and function relationships in IgA. Mucosal Immunol2011; 4: 590–597.
2.
BreedveldAvan EgmondM. IgA and FcαRI: pathological roles and therapeutic opportunities. Front Immunology2019; 10: 553.
3.
LeeAYSLinM-W. Polymeric IgA paraprotein on agarose gel electrophoresis immunofixation identifies a unique subset of IgA myeloma patients. Clinica Chim Acta2021; 512: 112–116.
4.
CeruttiA. The regulation of IgA class switching. Nat Rev Immunol2008; 8: 421–434.
5.
LinnikMDHuJZHeilbrunnKR, et al.Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum2005; 52: 1129–1137.
6.
SuiMLinQXuZ, et al.Simultaneous positivity for anti-DNA, anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis. J Clin Immunol2013; 33: 378–387.
7.
MariaNIDavidsonA. Emerging areas for therapeutic discovery in SLE. Curr Opin Immunol2018; 55: 1–8.
8.
SoniCReizisB. DNA as a self-antigen: nature and regulation. Curr Opin Immunol2018; 55: 31–37.
9.
ZhangJRoschkeVBakerKP, et al.Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. The J Immunol2001; 166: 6–10.
10.
MummertEFritzlerMJSjöwallC, et al.The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination. J Immunological Methods2018; 459: 11–19.
11.
Aas-HanssenKFunderudAThompsonKM, et al.Idiotype-specific Th cells support oligoclonal expansion of anti-dsDNA B cells in mice with lupus. The J Immunol2014; 193: 2691–2698.
12.
KimSJLeeKDiamondB. Follicular helper T cells in systemic lupus erythematosus. Front Immunol2018; 9: 1793.
13.
WoodsMZouY-RDavidsonA. Defects in germinal center selection in SLE. Front Immunol2015; 6: 425.
14.
GilkesonGSRuizPPippenAM, et al.Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med1996; 183: 1389–1397.
15.
WerleEBlazekMFiehnW. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescence test. Lupus1992; 1: 369–377.
16.
EnocssonHSjöwallCWirestamL, et al.Four anti-dsDNA antibody assays in relation to systemic lupus erythematosus disease specificity and activity. The J Rheumatol2015; 42: 817–825.
17.
ZigonPLakotaKCucnikS, et al.Comparison and evaluation of different methodologies and tests for detection of anti-dsDNA antibodies on 889 Slovenian patients’ and blood donors’ sera. Croat Medical Journal2011; 52: 694–702.
18.
VillaltaDRomelliPBSavinaC, et al.Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. Lupus2003; 12: 31–36.
19.
FörgerFMatthiasTOppermannM, et al.Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus2004; 13: 36–44.
20.
HashimotoHTsudaHTakasakiY, et al.Digital ulcers/gangrene and immunoglobulin classes/complement fixation of anti-dsDNA in systemic lupus erythematosus patients. The J Rheumatology1983; 10: 727–732.
21.
ShimodaMInoueYAmetaniA, et al.Anti‐DNA IgA autoantibodies are spontaneously generated in mouse Peyer’s patches. Immunology1998; 95: 200–207.
22.
KasaianMTCasaliP. B-1 cellular origin and VH segment structure of IgG, IgA, and IgM anti-DNA autoantibodies in patients with systemic lupus erythematosus. Ann New York Acad Sci1995; 764: 410–423.
23.
HandwergerBSStorrerCEWassonCS, et al.Further characterization of the autoantibody response of palmerston north mice. J Clin Immunol1999; 19: 45–57.
24.
SmithCINorbergRIsenbergD, et al.Anti-DNA antibody synthesis after bone marrow transplantation: implications for IgG subclass restrictivity and pathogenicity of autoantibodies. Bone Marrow Transplantation1988; 3: 583–588.
25.
WinklerTHHenschelTAKaliesI, et al.Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus. Clin Experimental Immunology1988; 72: 434–439.
26.
BootsmaHSpronkPEBorgEJT, et al.The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long term observation. Ann Rheum Dis1997; 56: 661–666.
27.
SteimanAJUrowitzMBIbañezD, et al.Anti-dsDNA and antichromatin antibody isotypes in serologically active clinically quiescent systemic lupus erythematosus. The J Rheumatol2015; 42: 810–816.
28.
MiltenburgAMRoosASlegtenhorstL, et al.IgA anti-dsDNA antibodies in systemic lupus erythematosus: occurrence, incidence and association with clinical and laboratory variables of disease activity. The J Rheumatology1993; 20: 53–58.
29.
ParodiADroseraMBarbieriL, et al.Antidouble-stranded DNA isotypes in lupus erythematosus patients with prevalent cutaneous presentation. Br J Dermatol2002; 147: 754–756.
30.
WitteTHartungKMatthiasT, et al.Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. Rheumatol Int1998; 18: 63–69.
31.
AttaAMPereiraMMSantiagoM, et al.Anti-dsDNA antibodies in Brazilian patients of mainly African descent with systemic lupus erythematosus: lack of association with lupus nephritis. Clin Rheumatol2009; 28: 693–697.
32.
VillaltaDBizzaroNBassiN, et al.Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. PLoS One2013; 8: e71458.
33.
JiaYZhaoLWangC, et al.Anti-double-stranded DNA isotypes and anti-C1q antibody improve the diagnostic specificity of systemic lupus erythematosus. Dis Markers2018; 2018: 4528547.
34.
GripenbergMHelveT. Anti-DNA antibodies of IgA class in patients with systemic lupus erythematosus. Rheumatol Int1986; 6: 53–55.
35.
KeisermanBRonchettiMRMonticieloOA, et al.Concomitance of IgM and IgG anti-dsDNA antibodies does not appear to associate to active lupus nephritis. The Open Rheumatology Journal2013; 7: 101–104.
36.
WerwitzkeSTrickDKaminoK, et al.Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB × NZW)F1 mouse. Arthritis Rheum2005; 52: 3629–3638.
37.
ShoenfeldYToubiE. Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential. Arthritis Rheum2005; 52: 2599–2606.
38.
NossentICHenzen-LogmansSCVroomTM, et al.Relation between serological data at the time of biopsy and renal histology in lupus nephritis. Rheumatol Int1991; 11: 77–82.
39.
YammaniRDLeyvaMAJenningsRN, et al.C4 deficiency is a predisposing factor for streptococcus pneumoniae-induced autoantibody production. J Immunol2014; 193: 5434–5443.
De RyckeLBaetenDKruithofE, et al.Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis. Arthritis Rheum2005; 52: 2192–2201.
42.
De RyckeLKruithofEVan DammeN, et al.Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. Arthritis Rheum2003; 48: 1015–1023.
43.
JónsdóttirTGunnarssonIRisseladaA, et al.Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response. Ann Rheumatic Diseases2008; 67: 330–334.
44.
FanopoulosDTeodorescuMRVargaJ, et al.High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J Rheumatology1998; 25: 675–680.
45.
Carmo-PereiraSBertolacciniMLEscudero-ContrerasA, et al.Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity. Ann Rheum Dis2003; 62: 540–543.
46.
HalseA-KMarthinussenMCWahren-HerleniusM, et al.Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjögren’s syndrome. Scand J Rheumatol2000; 29: 13–19.
47.
LeeAYSChatawayTColellaAD, et al.Quantitative mass spectrometric analysis of autoantibodies as a paradigm shift in autoimmune serology. Front Immunol2019; 10: 2845.
48.
WangJJColellaADBeroukasD, et al.Precipitating anti-dsDNA peptide repertoires in lupus. Clin Exp Immunol2018; 194: 273–282.
